Generating high-purity cardiac and endothelial derivatives from patterned mesoderm using human pluripotent stem cells.
about
Combinatorial Extracellular Matrix Microenvironments for Probing Endothelial Differentiation of Human Pluripotent Stem Cells.Chromatin and Transcriptional Analysis of Mesoderm Progenitor Cells Identifies HOPX as a Regulator of Primitive Hematopoiesis.3D Bioprinting and In Vitro Cardiovascular Tissue Modeling.A transcribed enhancer dictates mesendoderm specification in pluripotency.Cardiomyocyte Regeneration: A Consensus Statement.Specific Cell (Re-)Programming: Approaches and Perspectives.Co-Differentiation of Human Pluripotent Stem Cells-Derived Cardiomyocytes and Endothelial Cells from Cardiac Mesoderm Provides a Three-Dimensional Model of Cardiac Microtissue.Robust Revascularization in Models of Limb Ischemia Using a Clinically Translatable Human Stem Cell-Derived Endothelial Cell Product.Afterload promotes maturation of human induced pluripotent stem cell derived cardiomyocytes in engineered heart tissues.Inflammatory Responses and Barrier Function of Endothelial Cells Derived from Human Induced Pluripotent Stem Cells.Engineering Scalable Manufacturing of High-Quality Stem Cell-Derived Cardiomyocytes for Cardiac Tissue Repair.FOXD1-dependent MICU1 expression regulates mitochondrial activity and cell differentiationGeneration of Progesterone-Responsive Endometrial Stromal Fibroblasts from Human Induced Pluripotent Stem Cells: Role of the WNT/CTNNB1 PathwayThe detrimental effects of glucocorticoids exposure during pregnancy on offspring's cardiac functions mediated by hypermethylation of bone morphogenetic protein-4A Scalable and Efficient Bioprocess for Manufacturing Human Pluripotent Stem Cell-Derived Endothelial Cells
P2860
Q38659139-C891E922-A017-441B-944C-CC6C5C85204DQ41559939-18A685AE-A4B4-4148-8B0E-383FE9670CE7Q41670153-73C61CE4-210A-4C9B-9916-BDD6CEACD8AAQ47113021-611FF818-AAAA-4B07-9E47-C7AA5A6C5ACBQ47951585-EEB49F86-9B28-4298-9339-FECF074CADABQ50085975-7B852137-D24D-446C-8DBE-C885DAEA3610Q50087955-70F31EFC-C165-4FCE-835D-056BBA4EEBF0Q52716131-182E48A9-77DD-4779-931A-FF07A505EBAAQ52722649-7033AC1F-28A6-4A8C-BB81-2DE1BAEAC9BAQ55264050-540F2A9C-7E1C-41E6-93EC-C95D31421F43Q55287570-440ACDF6-FDA4-425E-B042-44645F6AA6C6Q58005048-39C0B54E-3D46-4091-8A34-8DF7A2A138CBQ58604035-CC86C326-A0E2-4C1C-8CB2-80F3DD2B8708Q58799618-8E96C31C-7680-4264-A0B5-20CF12478694Q58803059-1B78E217-33CB-4D3D-862B-CE28B8C11CA2
P2860
Generating high-purity cardiac and endothelial derivatives from patterned mesoderm using human pluripotent stem cells.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Generating high-purity cardiac ...... human pluripotent stem cells.
@en
type
label
Generating high-purity cardiac ...... human pluripotent stem cells.
@en
prefLabel
Generating high-purity cardiac ...... human pluripotent stem cells.
@en
P2093
P2860
P356
P1433
P1476
Generating high-purity cardiac ...... human pluripotent stem cells.
@en
P2093
Brandon Hadland
Charles E Murry
Irwin Bernstein
Meredith Roberts
Rebecca J Zaunbrecher
Ying Zheng
P2860
P2888
P356
10.1038/NPROT.2016.153
P577
2016-12-01T00:00:00Z
P6179
1044168746